Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Comment by alixx11on Aug 23, 2010 10:26pm

302 Views

Post# 17376729

RE: RE: RE: next ARZ joint venture or takeover

LE,

"We basically married a very rich partner with $5,000,000 to spend in very very very short order"
-- Not exactly so. Aurizon held a webcast earlier this month, and when discussing Niogold they stated that 2.5 million would be spect in 2010 and the rest in 2011. So the 5 mill. won't all be spent by Christmas, if that's what you were thinking.

"Where the heck are the assays?"
-- Well, with the new ARZ / NOX partnership planning to start drilling in September, I wouldn't hold my breath :) Probably no new results will be released until this new drill campaign is well under way. Maybe a news release in November?

A.

Bullboard Posts

Unique Battery Metals opportunity in Quebec